PL353989A1 - Sposób wytwarzania odmiany polimorficznej I olanzaSposób wytwarzania odmiany polimorficznej I olanzapinypiny - Google Patents

Sposób wytwarzania odmiany polimorficznej I olanzaSposób wytwarzania odmiany polimorficznej I olanzapinypiny

Info

Publication number
PL353989A1
PL353989A1 PL02353989A PL35398902A PL353989A1 PL 353989 A1 PL353989 A1 PL 353989A1 PL 02353989 A PL02353989 A PL 02353989A PL 35398902 A PL35398902 A PL 35398902A PL 353989 A1 PL353989 A1 PL 353989A1
Authority
PL
Poland
Prior art keywords
olansapine
obtaining
polymorphous form
polymorphous
obtaining polymorphous
Prior art date
Application number
PL02353989A
Other languages
English (en)
Other versions
PL196814B1 (pl
Inventor
JaninaPiechaczek Janina Piechaczek
MagdalenaGlice Magdalena Glice
UrszulaFrączek Urszula Frączek
JadwigaSerafin Jadwiga Serafin
WiesławSzelejewski Wiesław Szelejewski
KrzysztofSołtysiak Krzysztof Sołtysiak
Original Assignee
Instytut FarmaceutycznyInstytut Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut FarmaceutycznyInstytut Farmaceutyczny filed Critical Instytut FarmaceutycznyInstytut Farmaceutyczny
Priority to PL353989A priority Critical patent/PL196814B1/pl
Priority to AU2003251247A priority patent/AU2003251247A1/en
Priority to US10/514,520 priority patent/US7538213B2/en
Priority to EP03752952A priority patent/EP1509531A1/en
Priority to PCT/PL2003/000044 priority patent/WO2003097650A1/en
Publication of PL353989A1 publication Critical patent/PL353989A1/pl
Publication of PL196814B1 publication Critical patent/PL196814B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL353989A 2002-05-17 2002-05-17 Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty PL196814B1 (pl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PL353989A PL196814B1 (pl) 2002-05-17 2002-05-17 Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
AU2003251247A AU2003251247A1 (en) 2002-05-17 2003-05-16 Methods for preparation of olanzapine polymorphic form i
US10/514,520 US7538213B2 (en) 2002-05-17 2003-05-16 Methods for preparation of olanzapine polymorphic form I
EP03752952A EP1509531A1 (en) 2002-05-17 2003-05-16 Methods for preparation of olanzapine polymorphic form i
PCT/PL2003/000044 WO2003097650A1 (en) 2002-05-17 2003-05-16 Methods for preparation of olanzapine polymorphic form i

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL353989A PL196814B1 (pl) 2002-05-17 2002-05-17 Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty

Publications (2)

Publication Number Publication Date
PL353989A1 true PL353989A1 (pl) 2003-12-01
PL196814B1 PL196814B1 (pl) 2008-02-29

Family

ID=29546557

Family Applications (1)

Application Number Title Priority Date Filing Date
PL353989A PL196814B1 (pl) 2002-05-17 2002-05-17 Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty

Country Status (5)

Country Link
US (1) US7538213B2 (pl)
EP (1) EP1509531A1 (pl)
AU (1) AU2003251247A1 (pl)
PL (1) PL196814B1 (pl)
WO (1) WO2003097650A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL196814B1 (pl) 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
ATE500258T1 (de) 2002-05-31 2011-03-15 Sandoz Ag Verfahren zur herstellung von olanzapin form i
PL202856B1 (pl) * 2002-12-20 2009-07-31 Adamed Spo & Lstrok Ka Z Ogran Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny
EP1575962A1 (en) 2002-12-24 2005-09-21 Teva Pharmaceutical Industries Limited Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
DE602004014264D1 (de) 2003-12-22 2008-07-17 Teva Pharma Verfahren zur herstellung von olanzapin
WO2005070939A1 (en) * 2004-01-27 2005-08-04 Synthon B.V. Synthesis of olanzapine and intermediates thereof
WO2005070938A1 (en) 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
WO2005107375A2 (en) * 2004-05-06 2005-11-17 Matrix Laboratories Ltd Process for the preparation of olanzapine form-i
WO2006006180A1 (en) 2004-07-14 2006-01-19 Jubilant Organosys Limited A PROCESS FOR PRODUCING PURE FORM OF 2-METHYL-4-(4-METHYL-1-PIPERAZINYL)-10H-THIENO[2,3-b][1,5]BENZODIAZEPINE
ES2292333B1 (es) * 2004-07-27 2008-12-16 Inke, S.A. Mejoras en el objeto de la patente principal n. 200401850, por "solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo".
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
WO2006025065A1 (en) * 2004-08-31 2006-03-09 Lee Pharma Private Limited A process for the preparation of anhydrous olanzopine hydrochloride of form-1
US7829700B2 (en) 2004-09-06 2010-11-09 Shasun Chemicals And Drugs Limited Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
GB0522473D0 (en) * 2005-11-03 2005-12-14 Actavis Group A pharmaceutical formulation
ES2279715B1 (es) 2005-12-26 2008-06-01 Laboratorios Lesvi, S.L. Formulacion oral de olanzapina.
EP1968983B1 (en) 2006-01-05 2010-11-24 Inke, S.A. Method for preparing a mixed solvate of olanzapine
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
WO2007102167A1 (en) * 2006-03-06 2007-09-13 Lee Pharma Limited A process for the preparation of anhydrous polymorphic form of olanzapine
WO2007144901A1 (en) * 2006-06-12 2007-12-21 Jubilant Organosys Limited Process for stabilization of olanzapine polymorphic form i
PL381564A1 (pl) 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny
WO2008151430A1 (en) * 2007-06-14 2008-12-18 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
CN106265571A (zh) * 2016-08-31 2017-01-04 安徽省润生医药股份有限公司 一种奥氮平片剂的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
EG23659A (en) 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
EP0828494B1 (en) 1995-05-30 2002-07-17 Eli Lilly And Company Method for treating cognitive dysfunction
TR200100885T2 (tr) 1998-09-30 2001-08-21 Eli Lilly And Company 2-Metil-tieno-benzodiazepin formülasyonu
US6348458B1 (en) * 1999-12-28 2002-02-19 U & I Pharmaceuticals Ltd. Polymorphic forms of olanzapine
RU2003108745A (ru) * 2000-08-31 2005-01-10 Др. Редди`З Лабораториз Лтд. (In) Способ получения гидратов оланзапина и превращение их в кристаллические формы оланзапина
PL196814B1 (pl) 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty

Also Published As

Publication number Publication date
US7538213B2 (en) 2009-05-26
WO2003097650A1 (en) 2003-11-27
EP1509531A1 (en) 2005-03-02
PL196814B1 (pl) 2008-02-29
US20050239772A1 (en) 2005-10-27
AU2003251247A1 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
PL353989A1 (pl) Sposób wytwarzania odmiany polimorficznej I olanzaSposób wytwarzania odmiany polimorficznej I olanzapinypiny
GB0325192D0 (en) Method of use
EG23458A (en) Set of elements for assemlying structures
ZA200403741B (en) Method of timberland management
GB2424236B (en) Expansion method
EP1679388A4 (en) PROCESS FOR THERMAL SPRAYING
EP1577280A4 (en) DEUTERATION PROCESS
PL370561A1 (pl) Sposób wytwarzania zespołu okiennego
GB0310634D0 (en) Method of connecting components
EP1488046A4 (en) CONSTRUCTION METHODS
EP1512783A4 (en) KNITTING METHOD
IL162848A0 (en) Method of obtaining citalopram
GB0217812D0 (en) Method of calibrating cantilevers
AU2003299623A8 (en) Method of making mercaptoalkylalkyldialkoxysilanes
PL356465A1 (pl) Sposób wytwarzania 17beta-hydroksy-7alfa-metylo-19-nor-17alfa-pregn-5(10)-en-20-yn-3-onu
GB2450306B (en) Method of providing an airflow
PL351938A1 (en) Method of obtaining fructisiltransferase
GB0200049D0 (en) Method of manufacture
GB0219671D0 (en) Method of manufacture
PL357986A1 (pl) Sposób wytwarzania węglikostali
ZA200407527B (en) Method of facilitating employment
PL355451A1 (pl) Sposób wykonywania słupo-pala
PL347523A1 (en) Method of obtaining 11alpha-hydroxy-1-dehydrotestosterone
PL356317A1 (en) Method of obtaining alkanosulphonylpyridines
GB0204377D0 (en) Method of curcadian adjustment